Skip to content

Clinical trials

Observational Metabolic Syndrome trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Observational Country / region: United Kingdom Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20191
20201
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Unknown status2
Enrolling by invitation1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cambridge University Hospitals NHS Foundation Trust1
Liverpool John Moores University1
Loughborough University1
Perspectum1
South Tyneside and Sunderland NHS Foundation Trust1
University College, London1
University of Liverpool1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome7
Obesity3
Cardiovascular Diseases2
Non-alcoholic Fatty Liver Disease2
Acquired Immunodeficiency Syndrome1
Atherosclerosis1
COVID-191
Chronic Periodontitis1
Colorectal Neoplasms1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.